Abstract
Alzheimer’s disease (AD), a progressive neurodegenerative disease has become one of the major health issues in developed countries. Continuing our research on biological activity of coumarin derivatives, this study presents evaluation of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity of series 4- methylcoumarins. All studied compounds showed inhibitory activity in a similar manner as they are capable of scavenging reactive oxygen species and reducing transition metals. This study was focused on structural features that regulate biological activity of 4-methylcoumarins.
Keywords: 4-Methylcoumarins, acetylcholinesterase, antioxidant activity, butyrylcholinesterase.
Current Bioactive Compounds
Title:Cholinesterase Inhibition of Selected 4-Methylcoumarins in Comparison to their Antioxidant Activity
Volume: 10 Issue: 4
Author(s): Sanja C. Zeljkovic, Zbigniew Czarnocki, Anna Zawadzka, Miroslawa Panasiewicz and Franci Kovac
Affiliation:
Keywords: 4-Methylcoumarins, acetylcholinesterase, antioxidant activity, butyrylcholinesterase.
Abstract: Alzheimer’s disease (AD), a progressive neurodegenerative disease has become one of the major health issues in developed countries. Continuing our research on biological activity of coumarin derivatives, this study presents evaluation of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity of series 4- methylcoumarins. All studied compounds showed inhibitory activity in a similar manner as they are capable of scavenging reactive oxygen species and reducing transition metals. This study was focused on structural features that regulate biological activity of 4-methylcoumarins.
Export Options
About this article
Cite this article as:
C. Zeljkovic Sanja, Czarnocki Zbigniew, Zawadzka Anna, Panasiewicz Miroslawa and Kovac Franci , Cholinesterase Inhibition of Selected 4-Methylcoumarins in Comparison to their Antioxidant Activity, Current Bioactive Compounds 2014; 10 (4) . https://dx.doi.org/10.2174/1573407210666141001000556
DOI https://dx.doi.org/10.2174/1573407210666141001000556 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Association of PICALM Gene Polymorphisms with Alzheimer's Disease: Evidence from an Updated Meta-Analysis
Current Alzheimer Research Folic Acid, Neurodegenerative and Neuropsychiatric Disease
Current Molecular Medicine Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease
Current Pharmaceutical Design Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice
CNS & Neurological Disorders - Drug Targets Dual Cross-Talk between Nitric Oxide and D-Serine in Astrocytes and Neurons in the Brain
Central Nervous System Agents in Medicinal Chemistry Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Genetic Susceptibility to Prion Diseases in Humans and Mice
Current Genomics Editorial: (Thematic Issue: Vascular Pathophysiology of Alzheimer`s Disease)
Current Alzheimer Research Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer’s Disease: The Shanghai Aging Study
Current Alzheimer Research Vascular Cognitive Disorder: A Diagnostic and Pharmacological Treatment Updating
Current Psychopharmacology Prevalence and Predictors of Overweight and Obesity in Patients with Pituitary Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Plasma Steroid Level Measured Using Modern Separation Techniques as Biomarkers in Biological Diagnostics
Current Pharmaceutical Analysis Editorial [Hot Topic:Perspective on Mild Cognitive Impairment (MCI) (Guest Editor: Bernardino Ghetti)]
Current Alzheimer Research Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Current Pharmaceutical Design ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease
Current Drug Targets Antioxidant Pathways in Alzheimers Disease: Possibilities of Intervention
Current Pharmaceutical Design Beneficial Actions of Polyunsaturated Fatty Acids in Cardiovascular Diseases: But, How and Why?
Current Nutrition & Food Science Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway
Current Alzheimer Research Benefits of Caloric Restriction on Brain Aging and Related Pathological States: Understanding Mechanisms to Devise Novel Therapies
Current Medicinal Chemistry